DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clolar (Clofarabine) - Side Effect Reports to FDA

 
 



Index of reports > All Cases (95)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) all cases. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 95   Next >>

Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 121.9 kg (268.2 pounds)

Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epinephrine
    Dosage: 4 df, unk
    Indication: Cardiac Arrest
    Start date: 2012-07-14
    End date: 2012-07-14

Cyclophosphamide
    Dosage: daily for 5 days
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Oncaspar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-02
    End date: 2012-07-02

Epinephrine
    Dosage: unk
    Start date: 2012-07-14
    End date: 2012-07-14

Clolar
    Dosage: 74.4 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Vincristine Sulfate
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-02
    End date: 2012-07-02

Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: male, weighing 115.0 kg (253.0 pounds)

Reactions: Dyspnoea, Pneumonia, Haemoptysis, Rales, Musculoskeletal Pain, Hypotension, Pyrexia, Atrioventricular Block Second Degree, Lung Consolidation, Pulmonary Haemorrhage, Chest Pain, Tachypnoea, Pleural Effusion, Cough

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Busulfan
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-04
    End date: 2012-08-08

Clolar
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-03
    End date: 2012-08-08

Other drugs received by patient: Vancomycin; Zosyn; Micafungin; Voriconazole; Tacrolimus; Oxycodone HCL; Antibiotics; Methotrexate; Azithromycin; Neupogen; Coreg



Possible Clolar side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan



Possible Clolar side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate



Possible Clolar side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female

Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-12

Clolar
    Dosage: 52 mg/m2, dose level 3
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-13
    End date: 2012-07-17



Possible Clolar side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem



Possible Clolar side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: 61 year old male

Reactions: Dysstasia, Fatigue, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Busulfan
    Dosage: 254/332 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-28
    End date: 2012-07-01

Clolar
    Dosage: 83 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-27
    End date: 2012-07-01

Other drugs received by patient: Allegra; Omeprazole; Vfend; Megace; Prograf; Cyclosporine; Valaciclovir; Cell Cept; Loperamide; Ursodiol; Vancomycin; Cefpodoxime Proxetil; Colecalciferol; Humalog; Magnesium Sulfate; Prednisone TAB



Possible Clolar side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa



Possible Clolar side effects in female

Reported by a physician from Australia on 2012-07-19

Patient: female

Reactions: Atrial Fibrillation, Febrile Neutropenia, Constipation, Delusion, Haemoglobin Decreased, Fatigue, Myocardial Infarction, Hallucination, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-10-25
    End date: 2010-10-29

Clolar
    Dosage: unk
    Start date: 2010-11-29
    End date: 2010-12-03

Other drugs received by patient: Metformin Hydrochloride



Possible Clolar side effects in 63 year old female

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient: 63 year old female, weighing 125.2 kg (275.4 pounds)

Reactions: Urinary Tract Infection, Enterococcus Test Positive, Klebsiella Test Positive, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 30 mg/m2, qd, on days -6 through day -2
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-31
    End date: 2012-04-04

Thymoglobulin
    Dosage: 1.5 mg/kg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-26
    End date: 2012-03-30

Other drugs received by patient: Atovaquone; Mycophenolate Mofetil; Clonazepam; Nystatin; Heparin; Total Lymphoid Irradiation; Miconazole; Magnesium Sulfate; Filgrastim; Levetiracetam; Lacosamide; Senna-Mint WAF; Fluconazole; Cyclosporine; Valganciclovir; Ondansetron; Labetalol HCL; Vitamin D; Acetaminophen; Acetaminophen



Possible Clolar side effects in female

Reported by a pharmacist from United States on 2012-07-10

Patient: female

Reactions: Ejection Fraction Decreased

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: male, weighing 74.8 kg (164.6 pounds)

Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia, Abscess

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3820 mg, qd for induction treatment, for 5 days
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-16
    End date: 2012-03-20

Cytarabine
    Dosage: 3600 mg, qd, for 4 days
    Start date: 2012-04-28
    End date: 2012-05-01

Neupogen
    Dosage: 300 mcg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-15
    End date: 2012-04-04

Clolar
    Dosage: 57.3 mg, qd, for 5 days
    Start date: 2012-03-16
    End date: 2012-03-20

Neupogen
    Dosage: 300 mcg, qd
    Start date: 2012-04-28
    End date: 2012-05-01

Clolar
    Dosage: 46 mg, qd for consolidation treatment
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-28

Other drugs received by patient: Nicotine; Docusate; Lorazepam; Hydrocodone Bitartrate and Acetaminophen; Ondansetron (Zofran); Omeprazole; Lorazepam; Zolpidem; Acyclovir; Senna-Mint WAF; Oxycodone HCL; Levaquin; Voriconazole



Possible Clolar side effects in 63 year old female

Reported by a physician from United States on 2012-06-28

Patient: 63 year old female

Reactions: Urinary Tract Infection, Enterococcus Test Positive, Klebsiella Test Positive, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-01-01

Clolar
    Dosage: 30 mg/m2, qd, on days -6 through day -2
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-31
    End date: 2012-04-04

Other drugs received by patient: Filgrastim; Lacosamide; Acetaminophen; Levetiracetam; Nystatin; Cyclosporine; Heparin; Vitamin D; Valganciclovir; Atovaquone; Clonazepam; Magnesium Sulfate; Fluconazole; Labetalol HCL; Acetaminophen; Ondansetron (Zofran); Miconazole; Senna-Mint WAF; Total Lymphoid Irradiation; Mycophenolate Mofetil



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15

Patient: male, weighing 83.4 kg (183.5 pounds)

Reactions: Hepatic Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Acyclovir; Fluconazole; Ceftazidime; Filgrastim; Voriconazole



Possible Clolar side effects in 11 year old male

Reported by a physician from Argentina on 2012-06-14

Patient: 11 year old male

Reactions: Multi-Organ Failure, Cardiac Failure, Hypotension, Sepsis, Electrolyte Imbalance

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: unk

Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: unk

Etoposide
    Dosage: unk

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: male

Reactions: Sepsis, Febrile Neutropenia, Bradycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in 66 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: 66 year old male

Reactions: Febrile Neutropenia, Bradycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Clolar
    Dosage: 46 mg, qd for consolidation treatment
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-28

Clolar
    Dosage: for induction treatment
    Start date: 2012-03-16
    End date: 2012-03-20

Neupogen
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Oxycodone Hydrochloride; Docusate; Levaquin; Acyclovir; Hydrocodone Bitartrate and Acetaminophen; Lorazepam; Voriconazole; Nicotine; Omeprazole; Lorazepam; Zolpidem; Senna-Mint WAF; Ondansetron



Possible Clolar side effects in male

Reported by a physician from United States on 2012-06-04

Patient: male, weighing 83.4 kg (183.5 pounds)

Reactions: Hyperbilirubinaemia, Hypoalbuminaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Voriconazole; Acyclovir; Ceftazidime; Filgrastim; Fluconazole



Possible Clolar side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: 66 year old female

Reactions: Dyspnoea, Pericardial Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Indication: non-Hodgkin's Lymphoma

Clolar
    Dosage: 30 mg/m2, qdx5
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-01-14
    End date: 2012-01-18

Clolar
    Indication: non-Hodgkin's Lymphoma

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Dapsone; Acyclovir; Cholestyramine; Cyclosporine; Folic Acid; Lidocaine; Prilocaine Hydrochloride; Doxepin; Omeprazole; Sertraline Hydrochloride; Oxycodone HCL; Lorazepam



Possible Clolar side effects in 12 year old female

Reported by a physician from Argentina on 2012-05-25

Patient: 12 year old female

Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01

Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01

Cytoxan
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-07-01



Possible Clolar side effects in 64 year old male

Reported by a consumer/non-health professional from United States on 2012-05-24

Patient: 64 year old male

Reactions: Abdominal Pain, Post Transplant Lymphoproliferative Disorder, Nausea, Diarrhoea, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Indication: Stem Cell Transplant

Rituximab
    Dosage: protocol 09-346
    Indication: Post Transplant Lymphoproliferative Disorder

Clolar
    Dosage: 30 mg/m2, qd day -6 through -2
    Indication: Stem Cell Transplant
    Start date: 2012-02-04
    End date: 2012-02-08

Clolar
    Indication: Multiple Myeloma

Thymoglobulin
    Dosage: unk
    Indication: Multiple Myeloma

Bortezomib
    Dosage: protocol 09-346
    Indication: Post Transplant Lymphoproliferative Disorder

Rituximab
    Dosage: protocol 09-346 day 11

Bortezomib
    Dosage: protocol 09-346

Bortezomib
    Dosage: protocol 09-346, day 11

Rituximab
    Dosage: protocol 09-346

Other drugs received by patient: Acyclovir; Folic Acid; Multi-Vitamin; Albuterol; Cyclosporine; Pentamidine Isethionate; Oxycodone HCL; Prednisone; Amlodipine Besylate; Carvedilol; Lorazepam; Ondansetron; Prochlorperazine Maleate; Omeprazole; Colecalciferol



Possible Clolar side effects in male

Reported by a physician from Argentina on 2012-05-23

Patient: male

Reactions: Acute Lymphocytic Leukaemia, Device Related Sepsis, Vomiting, Rash Erythematous, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: male

Reactions: Hyperbilirubinaemia, Hypoalbuminaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Filgrastim; Acyclovir; Voriconazole; Fluconazole; Ceftazidime



Possible Clolar side effects in 7 year old female

Reported by a physician from Argentina on 2012-05-15

Patient: 7 year old female

Reactions: Acute Lymphocytic Leukaemia, Pigmentation Disorder, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2, qdx5

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5

Etoposide
    Dosage: 150 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Cyclophosphamide
    Dosage: 440 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Clolar
    Dosage: 40 mg/m2, qdx5
    Indication: Acute Lymphocytic Leukaemia Recurrent

Etoposide
    Dosage: 150 mg/m2, qdx5



Possible Clolar side effects in female

Reported by a pharmacist from United States on 2012-05-15

Patient: female

Reactions: Skin Reaction

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in female

Reported by a physician from United States on 2012-04-24

Patient: female, weighing 41.7 kg (91.7 pounds)

Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Stomatitis, Vomiting, Pain in Extremity, Nausea, Acute Lymphocytic Leukaemia, Renal Failure, Diarrhoea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar

Other drugs received by patient: Promethazine; Vinorelbine; Zosyn; Linezolid; Amphojel; Meropenem; Nystatin; Norvasc; Octreotide Acetate; Dexamethasone; Vinorelbine; Caphosol; Vinorelbine; Pepcid; Zoloft; Bactrim; Caspofungin Acetate; Thiotepa; RED Blood Cells, Concentrated; Platelets; Allopurinol; Acyclovir; Solutions FOR Parenteral Nutrition; Oxycodone HCL; Neupogen; Ondansetron; Lorazepam; Zithromax; Vfend; Vancomycin; Octreotide Acetate; Topotecan; Cefepime; Imodium; Dexamethasone; D5 1 / 2 NS + KCL 20 MEQ / L; Imodium



Possible Clolar side effects in male

Reported by a physician from United States on 2012-04-24

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Cardio-Respiratory Arrest, Mouth Haemorrhage, Unresponsive To Stimuli, Febrile Neutropenia, Pleural Effusion, Pancytopenia, Pneumonitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17

Patient: male, weighing 116.6 kg (256.5 pounds)

Reactions: Renal Failure, Pneumonia, Neutropenic Colitis, Neutropenic Sepsis, Hypotension, Pleural Effusion, Mental Status Changes, Staphylococcal Bacteraemia, Pulseless Electrical Activity

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Clolar
    Dosage: 94 mg, once
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-29
    End date: 2012-04-02

Busulfan
    Dosage: 249 mg, once
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-03-31

Clolar
    Indication: Bone Marrow Conditioning Regimen

Busulfan
    Dosage: 390 mg, once
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-04-01
    End date: 2012-04-02



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017